|
Volumn 54, Issue 6 SUPPL. 1, 1999, Pages 51-52
|
Summary: The role of the urologist in chemotherapy of hormone refractory prostate cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
CORTICOSTEROID;
ESTRAMUSTINE;
MITOXANTRONE;
PREDNISONE;
TAXANE DERIVATIVE;
BONE PAIN;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL TRIAL;
DRUG EFFICACY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
NOTE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATECTOMY;
SUBCUTANEOUS DRUG ADMINISTRATION;
TREATMENT OUTCOME;
|
EID: 0032785073
PISSN: 00904295
EISSN: None
Source Type: Journal
DOI: 10.1016/S0090-4295(99)00455-0 Document Type: Article |
Times cited : (2)
|
References (0)
|